The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

Subscribe

Title Date published
Drug pricing controversies (Delayed Recall October 2019) 2019-10-01
Combination therapy with nusinersen and AVXS-101 in SMA type 1 2019-09-30
MS and Vaccine Practice Guideline 2019-09-23
Gender Equity in Neurology + Drug Pricing Update Part 1 2019-09-16
Checkpoint Inhibitior Associated Neuropathy + Next Gen Sequencing Diagnosis of Encephalitis 2019-09-09
AAN Annual Meeting Plenary Session Speakers (Delayed Recall September 2019) 2019-09-03
Nerve Agent Poisoning Update + Brain Activity in Acute Brain Injury 2019-09-02
Zika update 2019 2019-08-26
A new paraneoplastic biomarker + Drug pricing controversies: “Evergreening” in pharma 2019-08-19
Impulse control and RBD in PD + CRISPR babies 2019-08-12
GAD Deposition in MS MRIs + Cervical Dystonia Network Localization 2019-08-05
More Neurology Minute Highlights (Delayed Recall August 2019) 2019-08-01
CDC’s Guideline on Pediatric Mild Traumatic Brain Injury: Recommendations for Neurologists 2019-07-29
Determining clinically meaningful decline in preclinical Alzheimer disease 2019-07-22
SUDEP in the North American SUDEP Registry: The full spectrum of epilepsies 2019-07-15
Use of ß2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease 2019-07-08
Current treatment practice of Guillain-Barré syndrome 2019-07-01
Epilepsy and EEG (Delayed Recall July 2019) 2019-07-01
Interview with Neurology Editor-in-Chief Dr. Bob Gross, pt. 2 2019-06-24
Interview with Neurology Editor-in-Chief Bob Gross, pt. 1 2019-06-17
1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556

Comments about Neurology® Podcast

comments powered by Disqus
Advertisment: